Racial differences in no-show rates for screening mammography
- PMID: 33792894
- PMCID: PMC8763332
- DOI: 10.1002/cncr.33435
Racial differences in no-show rates for screening mammography
Abstract
Background: Differences in utilization of screening mammography partly explain the increased breast cancer mortality observed in African American (AA) women compared with non-Hispanic White women. However, the contribution of noncompliance from women who do not come for their scheduled screening mammography appointment (ie, no-shows) is unknown. The purpose of this study was to investigate racial differences in no-show rates for screening mammography.
Methods: Women scheduled for routine screening mammograms between January 2018 and March 2018 were identified from the Joanne Knight Breast Health Center at Siteman Cancer Center in St. Louis, Missouri. Using a case-control design, this study retrospectively identified patients who no-showed for their mammograms (cases) and randomly sampled an equal number of patients who completed their mammograms (controls). These participants were compared by race. The main outcome measure was whether AA race was associated with no-shows for screening mammography.
Results: During the study period, 5060 women were scheduled for screening mammography, and 316 (6.2%) did not keep their appointment (ie, they no-showed). Women who no-showed were more likely to be AA than women who kept their appointment (odds ratio, 2.64; 95% confidence interval, 1.90-3.67). Even after adjustments for marital status, insurance type, and place of residence, AA race was still significantly associated with no-shows for screening mammography.
Conclusions: This study identified a no-show rate of 6.2% for screening mammography at the authors' institution. Women who no-showed were more likely to be AA than women who completed their mammogram even after adjustments for multiple factors. These data can be leveraged for future studies aimed at improving mammography attendance rates among AA women.
Keywords: African American; breast cancer; disparities; no-show; screening mammography.
© 2021 American Cancer Society.
Conflict of interest statement
Conflict of interest statement- FOA reports consulting for Eisai, Immunomedics, Astra Zeneca, Athenex, Cardinal Health, Pfizer, Abbvie, Best Doctors, and Advance Medical. FOA reports contracted research for Immunomedics, Pfizer, Seattle Genetics, NeoImmnue Tech, RNA Diagnostics, and Astellas.
Figures
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70: 7–30. - PubMed
-
- Screening mammography: a missed clinical opportunity? Results of the NCI Breast Cancer Screening Consortium and National Health Interview Survey Studies. Jama. 1990;264: 54–58. - PubMed
-
- Pace LE, He Y, Keating NL. Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer. 2013;119: 2518–2523. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
